Preliminary Considerations

For the sake of adequacy and systematization, the paper should follow the following structure, based on and adapted from the CARE methodology, which simplifies its objective and transparent assessment, as well as its presentation, reading and publication.

Standards for the abstract and paper
• Title: description of the main diagnosis or therapeutic intervention, ending with the words “clinical case” or ” cases series”
• Introduction: reference to the evaluative aspects of the case, which may include bibliographical references.
• Description of the clinical case
1. patient information,
2. specific information (such as gender and age), though not allowing for identification,
3. patient’s concerns, symptoms and expectations.
• Relevant data of the medical history
1. previous treatments carried out and their outcomes,
2. clinical data of the case resulting from clinical examination
3. diagnostic approach,
4. methods, complementary examinations, difficulties, already established diagnosis and others (if applicable).

4. Therapeutic intervention
1. type of intervention (preventive, pharmacological, surgical),
2. Description of intervention (procedures, materials, chronology), with photographs and complementary examinations carried out,
• Explanation of changes to traditional protocols, when applicable.
1. follow-up period and outcomes,
2. symptoms, morbidity, compliance and postoperative tolerance,
3. adverse side effects.
• Results obtained, effectiveness of the treatment.
1. diagnostic or other tests performed (photographs, x-rays, etc.),
2. description of important findings or of complementary interventions subsequently carried out (if applicable).
3. date of the last follow-up visit.

Discussion
1. Strengths and weaknesses of the case.
2. Reference to the most relevant literature.
3. Conceptual basis for the conclusions.

Patient’s perspective
1. If possible, record and describe the patient’s perspective and opinion about this treatment.

Conclusions
2. Conclusions to be drawn from the case, not longer than one paragraph
• Bibliography (see the General Considerations of these Guidelines)
• Final indication of sources of funding or support (if applicable)
• Conflict of interest disclosure statement (if any)
• Patient’s consent

If identification of the patient is necessary, the author(s) must also include the patient’s informed consent, as established in Art. 33, no. 6, and Art. 61, no. 1-d) of the OMD Code of Professional Conduct.